Hercules Technology Growth Capital, a specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, announced the appointment of Kristen Kosofsky as senior managing director in the Life Sciences Group in Hercules’ Boston office.
Kosofsky brings more than 20 years of experience in the venture debt market, focused on structuring financial transactions for biotechnology, medical device and other healthcare and select clean-tech related companies. Most recently, Kosofsky served as managing director at Horizon Technology Finance, and was responsible for business development in the life sciences market. Prior to Horizon, Kosofsky served as vice president, Life Sciences at Comerica Bank in Boston and co-led the life sciences practice. Before joining Comerica, Kosofsky worked in a number of finance and business development roles at GATX Corporation and Transamerica Technology Finance. Kosofsky began her career at Financing for Science International.
“I am pleased to welcome Kristen to Hercules and to have such an outstanding and seasoned investment professional join our industry-leading originations team,” stated Manuel A. Henriquez, chairman and chief executive officer of Hercules. “Kristen’s depth of experience and life sciences industry knowledge, coupled with her strong network is reflected in her proven track record of identifying, building and managing a high quality life sciences portfolio. Kristen has the right combination of skills to make significant contributions to our originations team as we continue to expand and execute on our growth plans in working with leading life sciences companies backed by some of the most prominent venture capital firms. I am confident Kristen will make numerous contributions to our company and our efforts to continue to drive earnings and dividend growth.”